| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.2499 (Miss by $-0.2101) |
| EPS GAAP Actual | $0.2499 (Miss by $-0.2101) |
| Revenue Actual | $-0.916779B |
| Revenue Surprise | Beat by $-916.779M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.22497 |
| EPS GAAP Estimate | $0.22497 |
| Revenue Estimate | $0.395637352B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.27 | 0.10028 | -0.916779B | 174.08% | -1367.89M |
| FQ2 2025 (Jun 2025) | 0.28 | 0.12033 | 0B | -INF% | -450.58M |
| FQ1 2025 (Mar 2025) | 0.3 | 0.3 | 0.459276B | 7.78% | 459.28M |
| FQ4 2024 (Dec 2024) | 0.33 | 0.33 | 0B | -INF% | 0M |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 0.679115B | 37.9% | 679.12M |
| FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 0.423494B | 6.6% | 423.49M |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 0.423555B | 6.1% | 423.56M |
| FQ4 2023 (Dec 2023) | 0.0002 | 0.0002 | 0.408657B | 100% | 408.66M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.22497
Consensus Revenue Estimates
0.395637352B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.18603 | -- | 0.1848 | 0.18695 | 1 |
| FQ3 2027 (Sep 2027) | 0.18798 | -- | 0.15842 | 0.19671 | 1 |
| FQ2 2027 (Jun 2027) | 0.1864 | -- | 0.15709 | 0.19506 | 1 |
| FQ1 2027 (Mar 2027) | 0.17299 | -- | 0.14579 | 0.18103 | 1 |
| FQ4 2026 (Oct 2026) | 0.23373 | -- | 0.19709 | 0.24763 | 3 |
| FQ3 2026 (Jul 2026) | 0.22415 | -20.46 | 0.18901 | 0.23748 | 5 |
| FQ2 2026 (Jun 2026) | 0.22415 | -24.92 | 0.19182 | 0.23462 | 5 |
| FQ1 2026 (Mar 2026) | 0.22497 | -33.35 | 0.19252 | 0.23547 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Sep 2027) | 0.57B | -- | 0.5B | 0.59B | 3 |
| FQ2 2027 (Jun 2027) | 0.55B | -- | 0.49B | 0.57B | 3 |
| FQ1 2027 (Mar 2027) | 0.54B | -- | 0.48B | 0.56B | 3 |
| FQ4 2026 (Oct 2026) | 0.42B | -- | 0.37B | 0.44B | 5 |
| FQ3 2026 (Jul 2026) | 0.4B | 330.84 | 0.35B | 0.42B | 5 |
| FQ2 2026 (Jun 2026) | 0.4B | -- | 0.35B | 0.41B | 6 |
| FQ1 2026 (Mar 2026) | 0.4B | -16.09 | 0.35B | 0.41B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16972 | 0.27 | 0.10028 | 37.14% |
| FQ2 2025 (Jun 2025) | 0.15967 | 0.28 | 0.12033 | 42.98% |
| FQ1 2025 (Mar 2025) | 0.3 | 0.3 | 100% | |
| FQ4 2024 (Dec 2024) | 0.33 | 0.33 | 100% | |
| FQ3 2024 (Sep 2024) | 0.51 | 0.51 | 100% | |
| FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 100% | |
| FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0002 | 0.0002 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.45B | $-0.92B | $-1367.89M | 149.21% |
| FQ2 2025 (Jun 2025) | $0.45B | $0B | $-450.58M | -INF% |
| FQ1 2025 (Mar 2025) | $0B | $0.46B | $459.28M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0.68B | $679.12M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.42B | $423.49M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.42B | $423.56M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.41B | $408.66M | 100% |